TaTME: analysis of the evacuatory outcomes and EUS anal sphincter.
Pedro LeãoCatarina SantosAndré GoulartAna Célia CaetanoMaria SousaGerrit HogemannAmjad ParvaizNuno L FigueiredoPublished in: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (2019)
Introduction: Some patients undergoing transanal total mesorectal excision (TaTME) may experience post-surgical complications, such as impaired bowel function and urogenital and sexual dysfunction. The present work aims to evaluate the one-year impact of TaTME surgery on bowel function, quality of life, and outcomes.Material and methods: Twenty patients undergoing TaTME with cancer in the mid and lower rectum were assessed prospectively by endoscopic transanal ultrasound (EUS) and three physiological function degrees, along with different clinical outcome questionnaires.Results: EUS sphincter evaluation revealed no structural impact in follow-up. For evacuatory evaluation, differences in the scores of the first postoperative month of Wexner questionnaires were shown when compared to a 12-month period. At least 10% of patients remain with major low anterior resection syndrome (LARS) after one year. The (Fecal incontinence Quality of Life) FiQoL questionnaire revealed that the cases in which values were worse in the first month posteriorly recovered to baseline preoperative values.Conclusions: TaTME does not seem to impact sphincter structure and evacuatory function, with a good recovery rate one year post-surgery, but does not seem to interfere with patients' evacuatory function quality of life.
Keyphrases
- patients undergoing
- minimally invasive
- end stage renal disease
- rectal cancer
- chronic kidney disease
- ejection fraction
- newly diagnosed
- coronary artery bypass
- ultrasound guided
- single cell
- magnetic resonance imaging
- risk factors
- adipose tissue
- case report
- urinary incontinence
- squamous cell carcinoma
- cross sectional
- patient reported
- psychometric properties
- acute coronary syndrome
- glycemic control
- insulin resistance
- contrast enhanced ultrasound
- percutaneous coronary intervention